Diagnostic options · UAE

Cytogenetics tests in Dubai & UAE

Compare available Cytogenetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

550.00–3,600.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cytogenetics test prices

Showing 16–30 of 30 matching tests.

Cytogenetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1707 CLL FISH Panel Test This test identifies chromosomal abnormalities (del(11q), trisomy 12, del(13q), del(17p)) in CLL patients to assess prognosis and guide therapy.	Bone marrow aspirate or Peripheral Blood	10 business days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal abnormalities: del(11q)", "Chromosomal abnormalities: trisomy 12", "Chromosomal abnormalities: del(13q)", "Chromosomal abnormalities: del(17p)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Diagnosis and prognosis of Chronic Lymphocytic Leukemia (CLL)", "Guiding therapy decisions in CLL"] Measurement technique Confirm with laboratory Codes LOINC: 53762-2 ICD-10: C91.1 Clinical summary This test identifies chromosomal abnormalities (del(11q), trisomy 12, del(13q), del(17p)) in CLL patients to assess prognosis and guide therapy.
TEST-1108 Fanconi Anemia Stress Cytogenetics Test This test evaluates chromosomal breakage in lymphocytes exposed to DNA cross-linking agents to diagnose Fanconi anemia.	Whole blood	7 working days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal breakage frequency", "DNA fragment analysis", "STR analysis"] Parameters [{"name": "Mean number of breaks per cell", "reference_range": "Validated against international Fanconi Anemia Research Fund guidelines (specific range not provided in text)"}] Preparation ["No fasting required.", "Provide a brief clinical summary including history of bone marrow failure, congenital anomalies, or family history of Fanconi anemia."] Indications ["Suspected Fanconi anemia", "Evaluation of bone marrow failure", "Assessment of congenital anomalies associated with Fanconi anemia"] Measurement technique Confirm with laboratory Codes LOINC: 9630-0 ICD-10: D61.09 Clinical summary This test evaluates chromosomal breakage in lymphocytes exposed to DNA cross-linking agents to diagnose Fanconi anemia.
TEST-1159 FISH Amniotic Fluid Two‑Probe Panel (Trisomy 13 & 21) Test This diagnostic test evaluates amniotic fluid for the presence of Trisomy 13 and Trisomy 21 using Fluorescence In-Situ Hybridization (FISH).	Amniotic fluid	4 working days (sample by 4 pm)	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosome 13 signal count", "Chromosome 21 signal count"] Parameters [] Preparation [] Indications ["Prenatal screening for Trisomy 13", "Prenatal screening for Trisomy 21"] Measurement technique Confirm with laboratory Codes LOINC: 33778-5 ICD-10: Q90.9, Q91.7 Clinical summary This diagnostic test evaluates amniotic fluid for the presence of Trisomy 13 and Trisomy 21 using Fluorescence In-Situ Hybridization (FISH).
TEST-490 FISH Analysis for X and Y Chromosomes Test This test evaluates the number and structure of X and Y chromosomes using fluorescent probes.	Amniotic fluid, Blood, Semen	1 week	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence and number of X chromosomes", "Presence and number of Y chromosomes", "Specific DNA sequences on X and Y chromosomes (DXZ1, DYZ3)"] Parameters [] Preparation [] Indications ["Prenatal screening for Turner syndrome (45,X)", "Prenatal screening for Klinefelter syndrome (47,XXY)", "Rapid fetal sex determination", "Infertility workup", "Evaluation of ambiguous genitalia"] Measurement technique Confirm with laboratory Codes LOINC: 29270-9 ICD-10: Z31.5 Clinical summary This test evaluates the number and structure of X and Y chromosomes using fluorescent probes.
TEST-483 Fluorescence In-Situ Hybridization (FISH) for Prenatal & Postnatal Diagnosis of Chromosomes 13 & 21 Test This diagnostic test evaluates for the presence of extra copies (trisomy) of chromosomes 13 and 21 using fluorescent probes.	Amniotic fluid, Chorionic villus sample, Peripheral blood	10–12 business days	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Numerical abnormalities of chromosome 13", "Numerical abnormalities of chromosome 21"] Parameters [] Preparation [] Indications ["Prenatal screening for Patau syndrome (trisomy 13)", "Prenatal screening for Down syndrome (trisomy 21)", "Postnatal diagnosis confirmation of suspected trisomy 13 or 21"] Measurement technique Confirm with laboratory Codes LOINC: 49498-0 ICD-10: Q90.9, Q91.7 Clinical summary This diagnostic test evaluates for the presence of extra copies (trisomy) of chromosomes 13 and 21 using fluorescent probes.
TEST-1474 Inv(16) (AML M4Eo) FISH Test This test detects the inv(16) / CBFB-MYH11 gene rearrangement, a specific genetic marker for Acute Myeloid Leukemia with Eosinophilia (AML M4Eo).	Bone Marrow / Peripheral Blood	3–4 days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBFB-MYH11 gene fusion", "Inversion 16 (inv(16))", "Variant translocation t(16;16)"] Parameters [] Preparation [] Indications ["Strong clinical suspicion of acute myeloid leukemia (AML)", "Risk stratification for AML", "Prognostic evaluation for AML"] Measurement technique Confirm with laboratory Codes LOINC: 60506-6 ICD-10: C92.5 Clinical summary This test detects the inv(16) / CBFB-MYH11 gene rearrangement, a specific genetic marker for Acute Myeloid Leukemia with Eosinophilia (AML M4Eo).
TEST-1355 Microarray 60K (POC) + Couple Karyotyping Test This diagnostic test evaluates chromosomal abnormalities in products of conception (POC) and parental blood using chromosomal microarray analysis (CMA) and G-banded karyotyping.	Products of conception tissue + Parental whole blood	7–9 days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Copy number variants (CNVs)", "Aneuploidy", "Uniparental disomy", "Triploidy", "Balanced rearrangements (translocations, inversions)"] Parameters [{"name": "Chromosomal Microarray (CMA)", "reference_range": "Detection of CNVs ≥200 kb"}, {"name": "G-banded Karyotyping", "reference_range": "Detection of chromosomal abnormalities ≥5-10 Mb"}] Preparation [] Indications ["Recurrent pregnancy loss (typically defined as 2 or more miscarriages)"] Measurement technique Confirm with laboratory Codes LOINC: 81278-6 ICD-10: N96 Clinical summary This diagnostic test evaluates chromosomal abnormalities in products of conception (POC) and parental blood using chromosomal microarray analysis (CMA) and G-banded karyotyping.
TEST-1344 Microarray 60K (POC) + Single Karyotyping Test This test evaluates products of conception and parental blood for chromosomal abnormalities associated with recurrent pregnancy loss.	Products of Conception (POC) Tissue & Parental Peripheral Blood	7–9 business days	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal aneuploidies", "Microdeletions", "Microduplications", "Structural rearrangements"] Parameters [] Preparation ["A valid physician prescription is mandatory prior to sample collection."] Indications ["Evaluation of recurrent pregnancy loss"] Measurement technique Confirm with laboratory Codes LOINC: 81264-9 ICD-10: O26.86 Clinical summary This test evaluates products of conception and parental blood for chromosomal abnormalities associated with recurrent pregnancy loss.
TEST-1341 Microarray 750K+ Single Karyotyping Test This test evaluates fetal, neonatal, or product-of-conception samples for chromosomal imbalances (copy number variations and loss of heterozygosity) using a high-resolution microar...	Fetal, neonatal, or product‑of‑conception samples (Amniotic fluid, CVS, cord blood, chorionic villi, formalin‑fixed paraffin‑embedded tissue)	7–9 Business Days	3,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Copy Number Variations (CNVs)", "Loss of Heterozygosity (LOH)", "Regions of Homozygosity"] Parameters [] Preparation ["Refrain from taking immunomodulatory drugs or anticoagulants 48 hours before sample collection, as advised by your physician.", "Anticoagulant therapy may require temporary adjustment prior to invasive sampling; coordinate with your prescribing physician."] Indications ["Prenatal diagnosis", "Neonatal assessment", "Product-of-conception analysis", "Neurodevelopmental assessment", "Recurrent pregnancy loss evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 82167-0 ICD-10: Z13.89, O35.1XX0, N96 Clinical summary This test evaluates fetal, neonatal, or product-of-conception samples for chromosomal imbalances (copy number variations and loss of heterozygosity) using a high-resolution microarray.
TEST-1335 MM Panel (Cytogenetics & FISH) Test This diagnostic test evaluates chromosomal deletions (11q, 13q, 17p) and IgH rearrangements in bone marrow cells using cytogenetics and FISH.	Bone Marrow Aspirate	5–7 Working Days	2,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal deletions (11q, 13q, 17p)", "IgH rearrangements", "Karyotype"] Parameters [] Preparation ["No specific patient preparation required."] Indications ["Diagnosis of multiple myeloma", "Prognostic risk stratification in multiple myeloma", "Guiding targeted therapy"] Measurement technique Confirm with laboratory Codes LOINC: 33715-1 ICD-10: C90.0 Clinical summary This diagnostic test evaluates chromosomal deletions (11q, 13q, 17p) and IgH rearrangements in bone marrow cells using cytogenetics and FISH.
TEST-1199 NTRK2 Gene Rearrangement FISH Assay Test This diagnostic test evaluates formalin-fixed paraffin-embedded (FFPE) tissue for chromosomal rearrangements involving the NTRK2 gene.	Archival tissue (FFPE block or 3 unstained slides on poly-L-lysine coated slides)	4 working days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NTRK2 gene rearrangements", "Chromosomal fusions"] Parameters [] Preparation [] Indications ["Identification of NTRK fusion-positive cancers", "Eligibility assessment for targeted therapy (e.g., larotrectinib, entrectinib)"] Measurement technique Confirm with laboratory Codes LOINC: 94240-2 ICD-10: C49.9 Clinical summary This diagnostic test evaluates formalin-fixed paraffin-embedded (FFPE) tissue for chromosomal rearrangements involving the NTRK2 gene.
TEST-1223 Peripheral Blood Karyotyping (Single) Test This test evaluates the number and structure of all 46 chromosomes in a peripheral blood sample.	Peripheral whole blood	7–9 business days from sample receipt	550.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosome number", "Chromosome structure"] Parameters [] Preparation ["Inform physician about all medications, over-the-counter drugs, and supplements.", "Do not stop or adjust prescribed medication without consulting your doctor."] Indications ["Recurrent pregnancy loss", "Suspected chromosomal syndromes", "Haematologic malignancies"] Measurement technique Confirm with laboratory Codes LOINC: 22400-9 ICD-10: Z01.5 Clinical summary This test evaluates the number and structure of all 46 chromosomes in a peripheral blood sample.
TEST-1236 Peripheral Blood Karyotyping for Couples Test This test evaluates the number and structure of chromosomes in peripheral blood cells from both partners.	Peripheral Whole Blood	10-12 Business Days	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal number (ploidy)", "Chromosomal structure (translocations, inversions, deletions, duplications)"] Parameters [] Preparation ["No fasting required.", "Discontinue heparin-containing products 24 hours prior to phlebotomy.", "Inform the phlebotomist of any blood transfusion within the preceding two weeks."] Indications ["Couple infertility workup", "Recurrent miscarriage investigation", "Pre-conception screening for chromosomal abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 53754-6 ICD-10: Z31.41, Z31.49 Clinical summary This test evaluates the number and structure of chromosomes in peripheral blood cells from both partners.
TEST-1187 Prenatal Diagnostic Screening by Karyotyping Test This test provides a definitive analysis of fetal chromosomes, identifying numerical and structural abnormalities.	Amniotic fluid or chorionic villus tissue	15–20 Working Days	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Fetal Chromosomal Set", "Chromosomal Aneuploidies", "Structural Rearrangements"] Parameters [] Preparation [] Indications ["Advanced maternal age", "Abnormal ultrasound markers", "Positive non-invasive screening result"] Measurement technique Confirm with laboratory Codes LOINC: 38285-2 ICD-10: Z36.2 Clinical summary This test provides a definitive analysis of fetal chromosomes, identifying numerical and structural abnormalities.
TEST-1067 Trisomy 8 (AML) Test This diagnostic test evaluates for the presence of an extra copy of chromosome 8 (Trisomy 8) in blood or bone marrow cells, a key prognostic marker in AML.	Bone Marrow (2–3 mL in sodium heparin tube) or Peripheral Blood (5 mL)	3–4 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosome 8 copy number", "Cytogenetic aberration in AML"] Parameters [] Preparation ["No specific fasting required", "Inform physician about all medications, especially chemotherapy, anticoagulants, or immunosuppressants"] Indications ["Diagnosis of Acute Myeloid Leukaemia (AML)", "Risk stratification in AML", "Minimal Residual Disease (MRD) monitoring in AML"] Measurement technique Confirm with laboratory Codes LOINC: 53631-7 ICD-10: C92.0 Clinical summary This diagnostic test evaluates for the presence of an extra copy of chromosome 8 (Trisomy 8) in blood or bone marrow cells, a key prognostic marker in AML.

Category overview

Cytogenetics: overview

Achieving a comprehensive understanding of your foundational chromosomal architecture is essential when navigating complex reproductive challenges, developmental delays, or suspected oncological conditions. As the cornerstone of our advanced Genetics services, comprehensive Cytogenetics screening involves the high-resolution microscopic and molecular evaluation of your cells to detect significant structural abnormalities, deletions, or duplications. By leveraging cutting-edge diagnostic technology, this expansive foundational profiling delivers the definitive data needed to diagnose complex genetic disorders and blood cancers, safely guiding your healthcare provider’s highly customized therapeutic strategies, targeted oncology protocols, and proactive family planning. Trusted for cytogenetic excellence among premier diagnostic labs in Dubai and the UAE, DNA Labs is steadfastly committed to strict patient confidentiality, uncompromising analytical accuracy, and incredibly efficient turnaround times. Prioritize your specialized healthcare journey—book your cytogenetics testing in UAE, arrange a seamless clinical sample collection, or consult our expert medical professionals today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.